Screening and diagnosis of HBV in low-income and middle-income countries (Q38953790)

7 September 2017

1 reference

title

Screening and diagnosis of HBV in low-income and middle-income countries (English)

1 reference

7 September 2017

Jean-Pierre Allain

1

1 reference

7 September 2017

Ohene Opare-Sem

series ordinal

2

1 reference

7 September 2017

language of work or name

English

0 references

publication date

14 September 2016

1 reference

Nature Reviews Gastroenterology & Hepatology

7 September 2017

1 reference

7 September 2017

13

1 reference

7 September 2017

11

1 reference

7 September 2017

643-653

1 reference

https://scigraph.springernature.com/pub.10.1038/nrgastro.2016.138

7 September 2017

0 references

cites work

HBV immunization and vaccine coverage among hospitalized children in Cameroon, Central African Republic and Senegal: a cross-sectional study

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Direct economic burden of hepatitis B virus related diseases: evidence from Shandong, China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

The economics of treating chronic hepatitis B in Asia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Cost-benefit comparison of two proposed overseas programs for reducing chronic Hepatitis B infection among refugees: is screening essential?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Combining rapid diagnostic tests and dried blood spot assays for point-of-care testing of human immunodeficiency virus, hepatitis B and hepatitis C infections in Burkina Faso, West Africa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Seroprevalence of chronic hepatitis B, as determined from dried blood spots, among children and their mothers in central Lao People's Democratic Republic: a multistage, stratified cluster sampling survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Hepatitis B viral load in dried blood spots: A validation study in Zambia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Validation of rapid point-of-care (POC) tests for detection of hepatitis B surface antigen in field and laboratory settings in the Gambia, Western Africa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Lessons learned from integrating simultaneous triple point-of-care screening for syphilis, hepatitis B, and HIV in prenatal services through rural outreach teams in Guatemala

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Superiority of minipool nucleic acid amplification technology for hepatitis B virus over chemiluminescence immunoassay for hepatitis B surface antigen screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Statements from the Taormina expert meeting on occult hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Validity of the rapid strip assay test for detecting HBsAg in patients admitted to hospital in Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

The risk of hepatitis B virus infection by transfusion in Kumasi, Ghana

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource-poor settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Performance of a new rapid test for the detection of hepatitis B surface antigen in various patient populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Performance evaluation of 70 hepatitis B virus (HBV) surface antigen (HBsAg) assays from around the world by a geographically diverse panel with an array of HBV genotypes and HBsAg subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Rapid point-of-care first-line screening tests for hepatitis B infection: a meta-analysis of diagnostic accuracy (1980-2010).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Evaluation of the performance of four rapid tests for detection of hepatitis B surface antigen in Antananarivo, Madagascar

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Risk factors associated with hepatitis B exposure and the reliability of five rapid kits commonly used for screening blood donors in Ghana

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Accuracy of Rapid Point-of-Care Diagnostic Tests for Hepatitis B Surface Antigen-A Systematic Review and Meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Hepatitis B surface antigenaemia and alpha-foetoprotein detection from dried blood spots: applications to field-based studies and to clinical care in hepatitis B virus endemic areas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Molecular and serological characterization of hepatitis B virus in deferred Ghanaian blood donors with and without elevated alanine aminotransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Maternofetal transmission of hepatitis B virus genotype E in Ghana, west Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Screening for viral markers in volunteer and replacement blood donors in West Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Seroepidemiology of hepatitis B virus infection and impact of vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Hepatitis B surface antigen prevalence among 12,393 rural women of childbearing age in Hainan Province, China: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

The estimation of prevalence and risk factors of hepatitis B virus infection among blood donors in Chengdu, China

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

The estimation of prevalence, incidence, and residual risk of transfusion-transmitted human hepatitis B infection from blood donated at the Anhui blood center, China, from 2009 to 2011

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Sensitivity and specificity of Anti-HBc screening assays--which assay is best for blood donor screening?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Evaluation of commercialized rapid diagnostic testing for some Hepatitis B biomarkers in an area of intermediate endemicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Assessment of dried blood spot samples as a simple method for detection of hepatitis B virus markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Hepatitis B virus infection among people attending the voluntary counselling and testing centre and anti-retroviral therapy clinic of St Paul's General Specialised Hospital, Addis Ababa, Ethiopia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

High prevalence of anti-hepatitis B core antigen in hepatitis B virus-vaccinated Chinese blood donors suggests insufficient protection but little threat to the blood supply

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Prevalence of "anti-HBc alone" among Syrian blood donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Seroprevalence of hepatitis B e antigen (HBe antigen) and B core antibodies (IgG anti-HBcore and IgM anti-HBcore) among hepatitis B surface antigen positive blood donors at a Tertiary Centre in Nigeria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Significance of detecting anti-HBc among Egyptian male blood donors negative for HBsAg.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

HBV: Do I treat my immunotolerant patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

High endemicity and low molecular diversity of hepatitis B virus infections in pregnant women in a rural district of North Cameroon

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Epidemiological characteristics of the carriers with coexistence of HBsAg and anti-HBs based on a community cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Coexistence of hepatitis B surface antigen and antibody to hepatitis B surface may increase the risk of hepatocellular carcinoma in chronic hepatitis B virus infection: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

One-year experience of nucleic acid technology testing for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus in Thai blood donations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Occult hepatitis B virus infection in Thai blood donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Occult hepatitis B infection in blood donors from South East Asia: molecular characterisation and potential mechanisms of occurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Nucleic acid testing to detect HBV infection in blood donors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Seroepidemiology of hepatitis B virus infection in 2 million men aged 21-49 years in rural China: a population-based, cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

The Serum Anti-HBs Level Among Children Who Received Routine Hepatitis B Vaccination During Infancy in Mianyang City, China: A Cross-Sectional Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

The long-term efficacy, 13-23 years, of a plasma-derived hepatitis B vaccine in highly endemic areas in China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Persistence of antibody to hepatitis B surface antigen among vaccinated children in a low hepatitis B virus endemic area

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Hepatitis B virus carrier rate, prevalence and susceptibility and impact of immunization program among households in the city of Taiz, Yemen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Hepatitis B virus exposure during childhood in Cameroon, Central African Republic and Senegal after the integration of HBV vaccine in the expanded program on immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

EASL Clinical Practice Guidelines: management of chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Comparison of Versant HBV DNA 3.0 and COBAS AmpliPrep–COBAS TaqMan assays for hepatitis B DNA quantitation: Possible clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Dried blood spot sampling for hepatitis B virus serology and molecular testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

A one-step dipstick assay for the on-site detection of nucleic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Rapid high-throughput genotyping of HBV DNA using a modified hybridization-extension technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Colorimetric detection of hepatitis B virus (HBV) DNA based on DNA-templated copper nanoclusters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Occult HBV infection in Morocco: from chronic hepatitis to hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Increased detection of HBV DNA in HBsAg-positive and HBsAg-negative South African HIV/AIDS patients enrolling for highly active antiretroviral therapy at a Tertiary Hospital.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Occult HBV infection in untreated HIV-infected adults in Côte d'Ivoire

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Presence of occult HBV, but near absence of active HBV and HCV infections in people infected with HIV in rural South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Characterization of occult hepatitis B virus strains in South African blood donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Hepatitis B virus transmission by blood transfusion during 4 years of individual-donation nucleic acid testing in South Africa: estimated and observed window period risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Prevalence and prevalence trends of transfusion transmissible infections among blood donors at four Chinese regional blood centers between 2000 and 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Impact of nucleic acid amplification test on screening of blood donors in Northern Pakistan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Hepatitis B virus nucleic acid testing in Chinese blood donors with normal and elevated alanine aminotransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Occult Hepatitis B Virus Infection in Nigerian Blood Donors and Hepatitis B Virus Transmission Risks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Occult hepatitis B virus infection among blood donors from the Brazilian Amazon: implications for transfusion policy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Characterization of occult hepatitis B virus infection from blood donors in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Evaluation of an individual-donation nucleic acid amplification testing algorithm for detecting hepatitis B virus infection in Chinese blood donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Enhanced detection of hepatitis B virus in Hong Kong blood donors after introduction of a more sensitive transcription-mediated amplification assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Sensitivity of individual-donation and minipool nucleic acid amplification test options in detecting window period and occult hepatitis B virus infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Infectivity of blood components from donors with occult hepatitis B infection - results from an Australian lookback programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Transmissibility of hepatitis B virus (HBV) infection through blood transfusion from blood donors with occult HBV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Infectivity of blood products from donors with occult hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Novel method for genotyping hepatitis B virus on the basis of TaqMan real-time PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Rapid fluorescent lateral-flow immunoassay for hepatitis B virus genotyping.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Overestimation of incidence of hepatitis B virus mixed-genotype infections by use of the new line probe INNO-LiPA genotyping assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Hepatitis B virus genotypes and genome characteristics in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Molecular epidemiology of HBV infection in chronic hepatitis B virus infected patients in northeast India

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Genotyping and virological characteristics of hepatitis B virus in HIV-infected individuals in Sudan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Genetic characterization and genotyping of hepatitis B virus (HBV) isolates from donors with an occult HBV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Pattern and molecular epidemiology of Hepatitis B virus genotypes circulating in Pakistan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Genotyping and molecular characterization of hepatitis B virus in liver disease patients in Kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Hepatitis B virus genotypes circulating in Brazil: molecular characterization of genotype F isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Subgenotypes and mutations in the s and polymerase genes of hepatitis B virus carriers in the West Bank, palestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Hepatitis B virus (HBV) infection and recombination between HBV genotypes D and E in asymptomatic blood donors from Khartoum, Sudan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Deletions and recombinations in the core region of hepatitis B virus genotype E strains from asymptomatic blood donors in Guinea, west Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Is there any value to hepatitis B virus genotype analysis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

The clinical implications of hepatitis B virus genotype: Recent advances.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Hepatitis B virus genotype, mutations, human leukocyte antigen polymorphisms and their interactions in hepatocellular carcinoma: a multi-centre case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Increased hepatocarcinogenic potential of hepatitis B virus genotype A in Bantu-speaking sub-saharan Africans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Diagnosis of hepatitis B virus infection through serological and virological markers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

The size of the viral inoculum contributes to the outcome of hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Pathogenesis of hepatitis B virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Management of Chronic Hepatitis B: An Overview of Practice Guidelines for Primary Care Providers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Hepatitis B e antigen-negative chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Isolated core antibody hepatitis B in sub-Saharan African immigrants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Impact of occult hepatitis B virus infection on the outcome of chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Occult hepatitis B infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Natural history of chronic hepatitis B virus infection and long-term outcome under treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Is response to antiviral treatment influenced by hepatitis B virus genotype?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Incidence and risk factors of progression to cirrhosis in inactive carriers of hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Management of hepatitis B in developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Antiviral therapy for chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

No resistance to tenofovir disoproxil fumarate through 96 weeks of treatment in patients with lamivudine-resistant chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Viral hepatitis in resource-limited countries and access to antiviral therapies: current and future challenges.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Nucleos(t)ide analogues only induce temporary hepatitis B e antigen seroconversion in most patients with chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Twenty-eight day safety, antiviral activity, and pharmacokinetics of tenofovir alafenamide for treatment of chronic hepatitis B infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Diagnostic accuracy of transient elastography (FibroScan) versus the aspartate transaminase to platelet ratio index in assessing liver fibrosis in chronic hepatitis B: the role in primary care setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Comparison of elastography, serum marker scores, and histology for the assessment of liver fibrosis in hepatitis B virus (HBV)-infected patients in Burkina Faso

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

The Gamma-Glutamyl-Transpeptidase to Platelet Ratio Does not Show Advantages than APRI and Fib-4 in Diagnosing Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis B: A Retrospective Cohort Study in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Performance of several simple, noninvasive models for assessing significant liver fibrosis in patients with chronic hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Epidemiology, diagnosis and treatment of chronic hepatitis B in HIV-infected patients (EPIB 2005 STUDY)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Impaired quality of the hepatitis B virus (HBV)-specific T-cell response in human immunodeficiency virus type 1-HBV coinfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Strategies for managing coinfection with hepatitis B virus and HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Treatment of chronic hepatitis B virus infection in resource-constrained settings: expert panel consensus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Epidemiology of Hepatocellular Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Occult HBV infection among a cohort of Nigerian adults.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

INNO-LiPA HBV genotyping is highly consistent with direct sequencing and sensitive in detecting B/C mixed genotype infection in Chinese chronic hepatitis B patients and asymptomatic HBV carriers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Natural history of chronic HBV infection in West Africa: a longitudinal population-based study from The Gambia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

HBsAg seroclearance in asymptomatic carriers of high endemic areas: appreciably high rates during a long-term follow-up

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Clearance of hepatitis B surface antigen and risk of hepatocellular carcinoma in a cohort chronically infected with hepatitis B virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Hepatitis B virus infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Occult hepatitis B virus infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.138

Individual donor nucleic acid testing for blood safety against HIV-1 and hepatitis B and C viruses in a tertiary care hospital

31 March 2020

1 reference

12 December 2020

Seroprevalence of transfusion-transmissible infectious agents among volunteer blood donors between 2006 and 2012 in Zhejiang, China

1 reference

12 December 2020

HIV/HBV Co-Infections: Epidemiology, Natural History, and Treatment: A Review Article

1 reference

12 December 2020

Pediatric HIV-HBV Coinfection in Lusaka, Zambia: Prevalence and Short-Term Treatment Outcomes

1 reference

12 December 2020

Significance of anti-HBc screening of blood donors and its association with occult hepatitis B virus infection: Implications for blood transfusion

1 reference

12 December 2020

Persistence of protection to hepatitis B vaccine and response to booster dose among children and adolescents in Dakahleya- Egypt.

1 reference

12 December 2020

Minimum infectious dose of hepatitis B virus in chimpanzees and difference in the dynamics of viremia between genotype A and genotype C.

1 reference

12 December 2020

Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection

1 reference

12 December 2020

Prevalence of hepatitis B virus seromarkers in young adults vaccinated at birth; impact on the epidemiology of hepatitis B infection in iran

1 reference

12 December 2020

APRI: a simple bedside marker for advanced fibrosis that can avoid liver biopsy in patients with NAFLD/NASH.

1 reference

12 December 2020

Diagnostic algorithm for HBV safe transfusion

1 reference

12 December 2020

The human immune response to hepatitis B surface antigen

1 reference

12 December 2020

10.1038/NRGASTRO.2016.138

Identifiers

DOI

1 reference

Dimensions Publication ID

7 September 2017

0 references

1 reference